Steel Grove Capital Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Steel Grove Capital Advisors's GILD Position: Q2 2025 in Review
Steel Grove Capital Advisors sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 20,978 shares — an estimated $2.35M sold.
Steel Grove Capital Advisors first reported a position in GILD in Q1 2021 and held it in 17 quarters. The position peaked at $2.55M in Q4 2022. 2,024 funds tracked by Wall St. Rank hold GILD as of Q2 2025.
- Steel Grove Capital Advisors reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
- Steel Grove Capital Advisors sold 20,978 Gilead Sciences shares in Q2 2025, an estimated $2.35M.
- Steel Grove Capital Advisors first reported a position in Gilead Sciences in Q1 2021 and held it in 17 quarters.
- Steel Grove Capital Advisors's Gilead Sciences position peaked at $2.55M in Q4 2022.
- 2,024 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.
Based on Steel Grove Capital Advisors's 13F filing for Q2 2025, filed 30 Jul 2025.